An international team of four renowned immunologists aims to explore immunotherapy for liver metastases. From left to right: Eric Vivier (Aix-Marseille Université, Assistance Publique Hôpitaux de Marseille, Centre d’Immunologie de Marseille-Luminy), Valeria Fumagalli (San Raffaele Hospital, Milan), Georg Gasteiger (Max Planck Research Group at the University of Würzburg), Florent Ginhoux (Gustave Roussy Cancer Campus, Paris). (Image: Eric Vivier)
An international team of four renowned immunologists aims to explore immunotherapy for liver metastases. From left to right: Eric Vivier (Aix-Marseille Université, Assistance Publique Hôpitaux de Marseille, Centre d'Immunologie de Marseille-Luminy), Valeria Fumagalli (San Raffaele Hospital, Milan), Georg Gasteiger (Max Planck Research Group at the University of Würzburg), Florent Ginhoux (Gustave Roussy Cancer Campus, Paris). (Image: Eric Vivier) Four distinguished immunologists have been awarded one of the most generously funded research grants from the EU: the ERC Synergy Grant. They aim to explore new avenues for immunotherapy of liver metastases. A significant proportion of cancer patients do not succumb to the initial tumor but rather to the resulting metastases. The growth of these secondary cancer sites is often challenging to curb with conventional therapies. Colorectal tumors, as well as many other types of tumors, frequently metastasize to the liver.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
